Skip to main content
. Author manuscript; available in PMC: 2009 Oct 30.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 Feb 22;49(6):2599–2605. doi: 10.1167/iovs.07-1508

Figure 2.

Figure 2

Representative fluorescein angiograms 2 weeks after laser treatment with power of 200 mW (A–D) and 400 mW (E–H) in WT (A, B, E, F) and LOXL1-deficient mice (C, D, G, H). Early-phase (1–2 minutes) and late-phase (6–8 minutes) frames are shown. LOXL1-deficient mice developed larger CNV lesions and showed increased angiographic leakage.